Related Experiment Videos
Diabetic management by insulin infusion during major surgery
American Journal of Surgery
|March 1, 1979
Summary
Intravenous insulin infusion offers superior glucose control in uremic diabetic patients undergoing renal transplantation compared to conventional subcutaneous insulin therapy. This method helps maintain target plasma glucose levels effectively during the perioperative period.
Area of Science:
- Nephrology
- Endocrinology
- Transplantation
Background:
- Uremic diabetic patients undergoing renal transplantation often experience glucose dysregulation.
- Maintaining optimal glycemic control is crucial for successful transplant outcomes.
Purpose of the Study:
- To evaluate the efficacy of low-dose intravenous insulin infusion for glycemic management in insulin-requiring, uremic diabetic patients during renal transplantation.
- To compare this method with conventional subcutaneous insulin therapy.
Main Methods:
- Five insulin-requiring, uremic diabetic patients received intravenous insulin infusions to maintain plasma glucose between 100-200 mg/100 ml.
- Insulin infusion rates were adjusted based on prednisone dosage and patient's body mass, using specific formulas.
- Results were compared to nineteen similar patients on conventional subcutaneous insulin therapy.
Main Results:
- Significantly better glucose control was achieved with the low-dose intravenous insulin infusion method.
- This approach facilitated tighter glycemic management compared to traditional subcutaneous insulin administration.
Conclusions:
- Low-dose intravenous insulin infusion is an effective strategy for glycemic control in uremic diabetic patients undergoing renal transplantation.
- This method provides superior glucose management compared to conventional subcutaneous insulin therapy in this patient population.